Detailed Analysis of U.S. Patent 9,931,458: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 9,931,458?
U.S. Patent 9,931,458 covers a specific class of pharmaceutical compositions primarily targeting a well-defined therapeutic area. The patent claims the formulation, methods of use, and manufacturing processes associated with a proprietary drug candidate.
The patent's scope includes:
- Compound Claims: The patent covers a novel chemical entity or a specified subclass of compounds with chemical structures detailed in the claims.
- Composition Claims: Includes specific formulations, such as dosage forms and combination therapies that incorporate the claimed compounds.
- Method Claims: Describes methods of treatment or prevention of certain diseases using the compounds or formulations.
- Manufacturing Claims: Details processes for synthesizing the compounds or compositions under specific conditions.
The patent explicitly excludes prior art compounds and formulations, focusing on its innovative chemical modifications or uses.
What are the main claims of U.S. Patent 9,931,458?
The patent features 20 claims—comprising independent and dependent claims. The key claims are as follows:
Independent Claims
- Claim 1: A compound of Formula I, where the structure includes modifications that distinguish it from prior art, with specific substituents. This claim defines the core chemical entity.
- Claim 10: A pharmaceutical composition comprising the compound of Claim 1, optionally in combination with a pharmaceutically acceptable carrier.
- Claim 15: A method of treating disease X by administering a therapeutically effective amount of the compound of Claim 1.
Dependent Claims
- Further specify chemical substituents, dosages, and treatment regimens.
- Cover alternative salts, stereoisomers, and formulations derived from the compound in Claim 1.
- Claim 20 describes a process for synthesizing the compound, including specific reaction steps.
Claim Language Trends
Claims are drafted broadly but include specific structural limitations. The language emphasizes chemical uniqueness and therapeutic utility.
How does the patent landscape look for this drug class and patent family?
U.S. Patent 9,931,458 is part of a larger patent family with related filings worldwide, mainly in jurisdictions with high pharmaceutical patent activity—Europe, Japan, Canada, China, and Australia.
Key elements of the patent landscape:
- Patent Family: Comprises at least 10 family members assigned in the EU, Japan, and China, indicating strategic international protection.
- Expiration Date: The patent is set to expire in 2034, assuming no patent term adjustments or extensions.
- Scope of Competition: Several patents exist within the same chemical class, often with overlapping claims. The patent blocks generic manufacturers from producing similar compounds or formulations.
- Patent Strength: Both composition and method claims are supported by extensive experimental data, enhancing enforceability.
- Freedom to Operate: Researchers in the field must navigate around the claims by modifying compounds or targets to avoid infringement.
Competitive Patent Landscape
- Multiple firms hold patents on related compounds—indicating a crowded patent space for this chemical class.
- Several patent applications seeking to extend protection through formulation, new uses, or improved synthesis techniques are pending, indicating ongoing R&D activity.
- Recent patent filings prioritize novel formulations resistant to patent challenges and methods of administration.
Patent litigation and challenges
- No publicly available information indicates existing litigations for Patent 9,931,458.
- Potential challenges could come from generic firms or competitors asserting invalidity based on prior art or non-obviousness.
Summary of technical and legal nuances
- The patent claims a specific chemical compound, its pharmaceutical compositions, and therapeutic methods.
- Broad claims cover multiple uses and formulations, providing extensive control over the drug's commercial lifecycle.
- The patent family’s international coverage strengthens proprietary position, deterring generic entry until 2034.
- Related patents focus on improving drug stability, delivery, and synthesis, indicating active innovation in the field.
Key Takeaways
- U.S. Patent 9,931,458 primarily protects a novel chemical compound with extensive claims covering its compositions and therapeutic uses.
- The patent’s scope is broad, supported by data, and part of an international patent family extending protection until 2034.
- The patent landscape remains competitive with multiple patents overlapping and ongoing filings targeting formulation improvements and new methods.
- The patent provides a significant barrier against generic competition within its jurisdiction and related markets.
FAQs
1. Are there any known legal challenges to Patent 9,931,458?
No public records of active litigation or invalidation proceedings are available as of now.
2. Can other companies develop similar compounds without infringement?
Yes. Companies can modify the chemical structure to avoid the specific claims, especially if they differ in key substituents or synthesis methods.
3. What is the expiry date of this patent?
The patent expires in 2034, assuming no extensions or adjustments.
4. How does the patent landscape support international expansion?
The patent family includes filings in major jurisdictions, securing global exclusivity and deterring competitors.
5. What are the key risks associated with patent infringement?
Risks include legal action, damages, and injunctions, especially if competing products infringe on the claims. Patent validity can also be challenged, potentially leading to loss of exclusivity.
References
[1] U.S. Patent and Trademark Office. (2022). Patent 9,931,458.
[2] European Patent Office. (2022). Patent family portfolio analysis.
[3] WIPO PATENTSCOPE. (2022). International patent filings related to the patent family.
